UBE2CP4

Across TCGA pan-cancer cohorts, UBE2CP4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated UBE2CP4 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher UBE2CP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2CP4 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.

UVM, ACC, and LUSC are the cancer types where UBE2CP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.231	0.726	<.001	99	view →
ACC	OS	Tertile	All	0.207	0.694	<.001	93	view →
LUSC	OS	Tertile	II,III,IV	0.749	0.541	.001	72	view →
KICH	OS	Tertile	III,IV	0.167	0.807	<.001	48	view →
THCA	OS	Tertile	III,IV	0.313	0.878	.012	21	view →
SKCM	DFS	Tertile	II,III,IV	0.779	0.668	.011	18	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
LUAD	DFS	Tertile	II,III,IV	0.528	0.751	.015	18	view →
THYM	OS	Tertile	III,IV	0.615	1.000	.019	9	view →
READ	OS	Median	IV	0.455	0.824	.005	8	view →
KIRC	DFS	Tertile	All	0.738	0.815	.022	6	view →
BRCA	DFS	Tertile	II,III,IV	0.677	0.498	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

UBE2CP4–UVM (OS)

Open the UVM breakdown →